Mode of Action Analysis and Biomarker Discovery Using Mass Spectrometry-Based Phosphoproteomics Technologies Andreas Jenne, CEO, Kinaxo, speaking at European Biomarkers Summit 2011.
Enabling High Throughput Mass Spectrometry for Compound Profiling of Enzyme Targets Melanie Leveridge, Scientist, GlaxoSmithKline, speaking at Screening Europe 2010
Targeted Metabolomics Applications of Mass Spectrometry in Biomedical and Environmental Analyses Ed Dudley, Lecturer, University of Swansea, speaking at Mass Spectrometry Europe 2010.
Progression of HCV Infection to Hepatocellular Carcinoma Radoslav Goldman, Associate Professor, Georgetown University, speaking at European Biomarkers Summit 2010.
Mass Spectrometry Based Serum Protein Profiling for the Early Detection of Breast Cancer Rob Tollenaar, Leiden University Medical Center, Professor of Surgical Oncology, speaking at Cancer Proteomics 2010.
Identification of Biomarkers in Plant Extracts using Liquid Chromatography Mass Spectrometry Analysis David Portwood of Syngenta, speaking at Advances in Metabolic Profilling.
Improved Protein Identifications from Human Plasma Samples Using a Genome Annotating Proteomic Pipeline Ian Shadforth, Enterprise Fellow, Cranfield University speaking at the European Biomarkers Summit 2006.
Imaging via LA-ICP-MS: Assessing Cancer Biomarkers Cliff Murray, Director of R&D, Medical Solutions plc. speaking at the European Biomarkers Summit 2006.
LC/MS/MS Solutions for Targeted and Non-Targeted Small Molecule and Protein Biomarker Discovery, Verification and Validation Henri Snijders, European Marketing Manager Small Molecules, Applied Biosystems speaking at the European Biomarkers Summit 2006.